Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.
about
Advances and challenges in the management of complement-mediated thrombotic microangiopathiesCurrent treatment of atypical hemolytic uremic syndromeAtypical hemolytic-uremic syndrome: a case report and literature reviewHaemolytic uraemic syndrome.An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.Podocyte dysfunction in atypical haemolytic uraemic syndrome.An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Successful living-related renal transplantation in a patient with factor H antibody-associated atypical hemolytic uremic syndrome.Anti-complement-factor H-associated glomerulopathies.Can eculizumab be discontinued in aHUS?: Case report and review of the literatureEfficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature reviewPlasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature.Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and IrelandCase Series of 3 Patients Diagnosed With Atypical Hemolytic Uremic Syndrome Successfully Treated With Steroids, Plasmapheresis, and Rituximab.
P2860
Q26796453-1087CE3B-5F14-483B-8FB0-2F240EC0F0D0Q27003211-75AA1AD6-22D8-4B21-8BF3-016758772102Q27003863-F2B4AEE5-EDE5-4E5F-8C1B-0D51203A6AFAQ30244707-21757A17-FF30-42C0-B9E1-E115EC2C4514Q33415218-C656BACF-CE8D-414F-A6B1-AEB7F86ABD87Q33417246-C3D60C61-8657-44E9-9751-3CFD7DA729E6Q33417644-82861BFC-9127-4EF1-9A54-3EBC9F42FB8BQ33419853-71B8A353-A20C-40C3-AECC-F3F35B4DA400Q33421861-668661DA-1495-471B-B3BB-F3FA70181AEAQ33423342-92BE837A-A624-413E-8BC4-1A8B211137B0Q33434103-986E8100-C9AB-4EC5-BECE-40B91EC7CF29Q33434378-0D3B9491-702F-4881-9BB2-A69502DE4774Q33435662-4333AEC9-9DB3-4A00-A32A-9596D9A422A7Q36306747-1A064476-DA60-42CE-9D98-D1977E8CE80CQ39309248-71CA9958-4B2B-40EF-B13E-D7ECFEF78FD5Q42650328-F1D14D57-6F58-41E0-8428-9E7F5A498F9AQ47144302-826ED0A8-66A1-4A32-8D3C-82C6057B1949
P2860
Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Long-term remission of atypica ...... after cyclophosphamide pulses.
@ast
Long-term remission of atypica ...... after cyclophosphamide pulses.
@en
type
label
Long-term remission of atypica ...... after cyclophosphamide pulses.
@ast
Long-term remission of atypica ...... after cyclophosphamide pulses.
@en
prefLabel
Long-term remission of atypica ...... after cyclophosphamide pulses.
@ast
Long-term remission of atypica ...... after cyclophosphamide pulses.
@en
P2093
P2860
P50
P1433
P1476
Long-term remission of atypica ...... after cyclophosphamide pulses.
@en
P2093
Caroline Rousset-Rouvière
Etienne Bérard
Gwenaëlle Sana
Karim Bouchireb
Marina Charbit
Patrick Niaudet
Rémi Salomon
Véronique Frémeaux-Bacchi
P2860
P2888
P356
10.1007/S00467-013-2558-9
P577
2013-07-19T00:00:00Z
P5875
P6179
1040045929